$INCY $EVTCY $ACRX $CNCE: Concert Pharma’s CTP-692 Positive for Schizophrenia in Phase I

Date: Thursday, June 13th, 2019

Stock(s) mentioned: , , ,

Source: Zacks.com (https://www.zacks.com)

Summary: Concert Pharma (CNCE) reports favorable data from the two early-stage studies on its pipeline candidate, CTP-692, currently under evaluation as an adjunctive treatment for schizophrenia. Share rise.

Full article address: https://www.zacks.com/stock/news/429331/Concert-Pharmas-CTP692-Positive-for-Schizophrenia-in-Phase-I

Related News:

$ACRX $AT: Hedge Funds Have Never Been More Bullish On AcelRx …

$ACRX: AcelRx announces the closing of a $25 million senior secured debt …

$ACRX: After Years Of Development, AcelRx’s Dsuvia Has Finally Generated …

$ACRX: Here’s Why AcelRX Pharmaceuticals Fell as Much as 14% Today

$ACRX: AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vince Angotti on Q1 …

$HZNP $INO $GNMSF $ACRX: What’s in the Cards for AcelRx (ACRX) This Earnings Season?

$ACRX $TDOC $BMY: 3 Stocks Peter Lynch Would Love

$ACRX: AcelRx to announce first quarter 2019 results and provide an update …

$ACRX $ZBH: Needham likes Zimmer Biomet in premarket analyst action

$ACRX: AcelRx Pharmaceutical’s pooled safety results for sufentanil …

$ATNM $OTIC $KALV $ACRX $MTEM: Small Drugmakers Outperforming the Bigshots: 7 Stocks to Buy

Latest News:

$PLD $BX: The Wall Street Journal: Prologis buying Industrial Property Trust, a rival REIT, in $3.9 billion deal

$FB $GOOGL: Tech investor Peter Thiel thinks Elizabeth Warren is the most ‘dangerous’ Democrat against Trump

$BABA $TCEHY $NTES $ATVI $HUYA $PDD: 5 Takeaways About China’s Tech Landscape from a Stat-Filled Report

$RTN: China warns it will cut ties with any US firm connected to Taiwan arms deal

$MU $DJI $VMW $DELL $MRVL: Cramer Remix: What to make of the inverted yield curve this earnings season

$BMY $LLY $DD $MRVL $GM $KHC: Bristol-Myers Squibb, Eli Lily, DuPont: ‘Mad Money’ Lightning Round

$YOGA: CORRECTING and REPLACING YogaWorks Announces Delisting …

$PLD: Prologis Reports Second Quarter 2019 Earnings Results and …

$HSDT: Glancy Prongay & Murray Reminds Investors of Looming Deadline …

$OMCL: OMCL INVESTIGATION Update: Hagens Berman Updates Omnicell …

$JKS: JinkoSolar Commended for Its High-efficiency Solar Module …